Omeros Stock Today
| OMER Stock | USD 8.42 0.56 7.12% |
PerformanceInsignificant
| Odds Of DistressQuite High
|
Omeros is selling at 8.42 as of the 15th of March 2025; that is 7.12% increase since the beginning of the trading day. The stock's lowest day price was 7.94. Omeros has more than 61 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 15th of December 2024 and ending today, the 15th of March 2025. Click here to learn more.
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company has 57.95 M outstanding shares of which 9.45 M shares are now shorted by private and institutional investors with about 20.01 trading days to cover. More on Omeros
Moving against Omeros Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Omeros Stock Highlights
Omeros (OMER) is traded on NASDAQ Exchange in USA. It is located in The Omeros Building, Seattle, WA, United States, 98119 and employs 198 people. Omeros is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 455.49 M. Omeros conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 57.95 M outstanding shares of which 9.45 M shares are now shorted by private and institutional investors with about 20.01 trading days to cover.
Omeros currently holds about 122.56 M in cash with 74.73 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.95.
Check Omeros Probability Of Bankruptcy
Ownership AllocationOmeros owns a total of 57.95 Million outstanding shares. 30% of Omeros outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Omeros Ownership Details
Omeros Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Omeros market risk premium is the additional return an investor will receive from holding Omeros long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.058 | |||
| Jensen Alpha | 0.7046 | |||
| Total Risk Alpha | 1.29 | |||
| Sortino Ratio | 0.0972 |
Omeros Stock Against Markets
Omeros Corporate Management
| Peter JD | General VP | Profile | |
| Nadia Dac | VP Officer | Profile | |
| Debra MT | Chief Officer | Profile | |
| David Ghesquiere | Chief Officer | Profile | |
| Andreas MD | Chief Officer | Profile | |
| Gregory MD | Chairman, CoFounder | Profile |
Additional Tools for Omeros Stock Analysis
When running Omeros' price analysis, check to measure Omeros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omeros is operating at the current time. Most of Omeros' value examination focuses on studying past and present price action to predict the probability of Omeros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omeros' price. Additionally, you may evaluate how the addition of Omeros to your portfolios can decrease your overall portfolio volatility.